drugset

drugset / Trial / NCT01810302

Safety Study of Nicardipine to Treat Cerebral Vasospasm

NCT01810302 ↗

Phase 2 Terminated 2 enrolled University of Florida

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if intrathecal nicardipine is safe for the treatment of cerebral vasospasm.

Timeline

Start: 2013-08
Primary completion: 2014-01
Completion: 2014-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Nicardipine	Small molecule	4 mg	Intrathecal

Indications